Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Maintenance in Esophageal Cancer
NCT06598917Phase 2Not yet recruiting
- Sponsor
- China Medical University Hospital
- Start
- Oct 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tegafur in esophageal cancer, sponsored by China Medical University Hospital. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
tegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT06598917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06598917.